Trigen Laboratories

Trigen Laboratories is a U.S. generic pharmaceutical company focused on developing, sourcing, commercializing, and supplying a broad portfolio of affordable generic and non-promoted pharmaceutical products. Founded in 2003, the company operates as a vertically integrated generic business spanning product development, regulatory support, quality, supply chain management, sales, and commercialization. Its marketed portfolio includes complex generic formulations as well as prescription products and practitioner-directed nutritional products in areas such as ADHD, pain, women’s health, and supplementation. Trigen became part of Osmotica Pharmaceuticals in 2015 and now operates within the Alora Pharmaceuticals family of companies. The business appears to focus on the U.S. market rather than on novel R&D or an independent clinical pipeline.